| Name | Title | Contact Details |
|---|
DMS Health Group is a Fargo, ND-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
More commonly known as Columbia County Health System and Dayton General Hospital, the Columbia County Public Hospital District #1 was established in 1960 with the vision and mission of providing high quality healthcare to our local communities. We are a 25-bed, Critical Access Hospital with Level V Trauma Center, Level III Cardiac and Stroke Center designations. Additionally, we are the regions primary wound care and hyperbaric therapy treatment center. Our primary service areas include Dayton, Waitsburg, Starbuck, and the surrounding region. We are comprised of Columbia Family Clinic, Waitsburg Clinic, Booker Rest Home, and Dayton General Hospital with our Rural Health Clinics open for primary care and behavior health services 6 days a week. We are fully staffed with 3 primary care medical doctors, a board-certified emergency medicine doctor, a board-certified pediatrician, 4 mid-level family practice providers, and dermatology focused ARNP. Our Emergency Department is staffed with our employed providers as well as partner physicians. In addition to Acute Care services, we offer inpatient care for sub-acute, Swing Bed patients, which are patients that need a step down from acute care, but still require skilled nursing care and/or various rehabilitation therapies for an extended period. This service allows patients, who may have had a qualifying, Acute hospitalization or surgery, to return to our facility and receive hospital class nursing and rehabilitation services for an extended period.
Inteleso is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Moda Technology Partners is a Wayne, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. Based on widely used generic drugs that currently require intravenous or intramuscular injections, our innovative products will be administered subcutaneously via a proprietary patch pump. This avoids material risks and costs associated with the current delivery options. Our lead products are the first subcutaneous formulations of furosemide (the most widely used parenteral diuretic in treating heart failure) and ceftriaxone (the most widely used parenteral antibiotic outside the hospital setting). Our novel furosemide formulation enables convenient anytime anywhere use, for example in an outpatient setting instead of the emergency room or other in-patient settings. For ceftriaxone and other antibiotics, subcutaneous administration eliminates the need for PICCs (peripherally inserted central catheters), which are associated with serious complications, frequent adverse events and high medical cost. For further information on how we are transforming the administration of parenteral drugs.